bluebird bio Inc (NAS:BLUE)
$ 0.405 0.0272 (7.2%) Market Cap: 78.75 Mil Enterprise Value: 376.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

bluebird bio Inc to Present New Data at the European Hematology Association (EHA) Congress Conference Call Transcript

Jun 14, 2019 / 12:00PM GMT
Release Date Price: $76.17 (-5.07%)
Operator

Good day, ladies and gentlemen, and welcome to the EHA Data Review and ZYNTEGLO Approval Webcast Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to introduce your host for today's conference, Ms. Jenn Snyder, Head of Corporate Communications. You may begin.

Jenn Snyder
bluebird bio, Inc. - VP of Corporate Communications

Thank you, operator, and good morning, everyone. Thank you for joining this morning's call. We issued 2 press releases today on data from our programs being presented this year at EHA, which can be found on the Investor Relations section of our website.

Before we begin, let me review our safe harbor statement. Today's discussion contains statements that are forward-looking under the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations and assumptions that are subject to risks and uncertainties and involve a number of risk factors that could cause actual results to differ materially from projected results. In

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot